BTIG Upgrades Doximity (DOCS) Stock to Buy from Neutral
On June 2, BTIG analysts upgraded Doximity, Inc.
Insider Monkey Blog
RBC Capital Upgrades Church & Dwight Co. (CHD), Lifts PT
On June 2, analysts at RBC Capital Markets upgraded Church & Dwight Co., Inc.
Desjardins Upgrades BRP (DOOO) Stock, Lifts PT
On May 30, Desjardins analyst Benoit Poirier upped BRP Inc.
National Bank Financial Downgrades Royal Bank of Canada (RY) Stock, Reduces PT
On May 30, National Bank Financial downgraded Royal Bank of Canada (NYSE:RY)’s stock from “Outperform” to “Sector Perform,” reducing its price target to C$177.00 from...
Evercore ISI Downgrades Rocket Pharmaceuticals (RCKT) Stock, Slashes PT
On May 30, Evercore ISI downgraded Rocket Pharmaceuticals, Inc.
Piper Sandler Downgrades Zscaler (ZS) Stock, Raises PT
On May 30, Piper Sandler analysts changed their rating on Zscaler, Inc.
Loop Capital Keeps Buy Rating on Costco (COST), Lowers PT
On Friday, May 30, Loop Capital Markets lowered its price target slightly on Costco Wholesale Corporation (NASDAQ:COST) from $1,115 to $1,110 and maintained a “Buy” rating...
DA Davidson Lifts Duolingo (DUOL) Price Target, Keeps Buy Rating
Swanson’s analysis shows that Duolingo, Inc.’s (NASDAQ:DUOL) daily active user (DAU) growth in the second quarter is exceeding the consensus forecast of 43.7% year-over-year...
TD Cowen Lifts L3Harris (LHX) Price Target, Keeps Buy Rating
On Friday, May 30, TD Cowen analyst Gautam Khanna increased the price target on L3Harris Technologies, Inc. (NYSE:LHX) from $240 to $270 and maintained a “Buy” rating.
BMO Lifts Roblox (RBLX) Price Target, Keeps Outperform Rating
On Friday, May 30, BMO Capital Markets raised the price target for Roblox Corporation (NYSE:RBLX) from $82 to $95 and maintained an “Outperform” rating.
BofA Keeps Buy Rating on Coupang (CPNG), Lifts PT
This decision came after a report from the South Korean Ministry of Trade, Industry and Energy (MoTIE), which showed that sales for retail and e-commerce companies surveyed in...
DA Davidson Keeps Buy Rating on Boise Cascade (BCC) Despite Market Challenges
On Friday, May 30, DA Davidson maintained a “Buy” rating on Boise Cascade Company (NYSE:BCC) with a price target of $115.
SolarEdge Technologies Inc. (SEDG) and Flex Ltd. (FLEX) Announce Major Manufacturing Achievement in Austin
On June 2, 2025, SolarEdge Technologies, Inc. (NASDAQ:SEDG) achieved a significant milestone in its U.S.
Citi Raises 3M (MMM) Price Target, Keeps Neutral Rating
On Friday, May 30, Citi analyst Andrew Kaplowitz increased the price target for 3M Company (NYSE:MMM) from $141 to $160 and reiterated a “Neutral” rating.
Citi Lowers The Gap Inc (GAP) Price Target, Keeps Buy Rating
On Friday, May 30, Citi analyst Paul Lejuez lowered the price target for The Gap, Inc. (NYSE:GAP) to $30 from $33 and kept a “Buy” rating.
Deutsche Bank Resumes Coverage of Ralph Lauren (RL) With Buy Rating
On Friday, May 30, Deutsche Bank resumed coverage of Ralph Lauren Corporation (NYSE:RL), giving a “Buy” rating with a $343 price target.
China Galaxy Downgrades PDD Holdings (PDD) to Hold, Lowers PT
On Friday, May 30, China Galaxy International analyst Lei Yang changed the rating for PDD Holdings Inc.
Needham Lowers Marvell (MRVL) Price Target, Reiterates Buy Rating
On Friday, May 30, Needham analyst N. Quinn Bolton reduced the price target for Marvell Technology, Inc. (NASDAQ:MRVL) from $100 to $85 and reiterated a “Buy” rating.
Needham Boosts Zscaler (ZS) Price Target, Keeps Buy Rating
On Friday, May 30, Needham raised the price target for Zscaler, Inc. (NASDAQ:ZS) from $240 to $310 and maintained a “Buy” rating.
ScanTech AI Delivers 6th Sentinel CT System Under $3.5M Nuclear Security Contract
On Monday, ScanTech AI Systems Inc. (NASDAQ:STAI) announced the successful delivery of its 6th Sentinel Fixed-Gantry CT system.
OceanPal Sells Dry Bulk Vessel ‘Protefs’ for $7M, Streamlines Fleet
On Monday, OceanPal Inc. (NASDAQ:OP) announced the sale of its 2004-built dry bulk vessel, under the name of Protefs.
Tempus AI Unveils New Liquid Biopsy Assay for Early Immunotherapy Response Monitoring in Cancer
On Monday, Tempus AI Inc. (NASDAQ:TEM) announced the introduction of xM for treatment response monitoring/TRM.
Baker Hughes, Cactus Enter Joint Venture for Surface Pressure Control Services
On Monday, Baker Hughes Company (NASDAQ:BKR) and Cactus Inc.
BriaCell’s Bria-IMT Shows Strong Survival & Benefit in Advanced Breast Cancer
On Monday, BriaCell Therapeutics Corp.
Relay Therapeutics’ RLY-2608 Shows Promising 11-Month PFS in Breast Cancer
On Monday, Relay Therapeutics Inc.
Honda Motor Co., Ltd. (HMC) Signs On as Key Partner for 2028 Los Angeles Olympics
Honda Motor Co., Ltd. (NYSE:HMC) has become a major partner for the 2028 Olympic and Paralympic Games in Los Angeles.
Williams Trading Lifts Shoe Carnival (SCVL) PT to $21 on Strong Q1 2025 Earnings
On Monday, Williams Trading analyst Sam Poser increased the price target for Shoe Carnival Inc. (NASDAQ:SCVL) to $21 from $17, while maintaining a Hold rating on the stock.
Truist Initiates Coverage of Global-e (GLBE) with Sell Rating
On Monday, Truist initiated coverage on Global-E Online Ltd. (NASDAQ:GLBE) with a Sell rating and a $31 price target.
BMO Capital Initiates Coverage of Aspen Insurance (AHL) with Outperform Rating
On Monday, BMO Capital initiated coverage of Aspen Insurance Holdings Limited (NYSE:AHL) with an Outperform rating and a price target of $38.
BMO Capital Downgrades Algoma Steel (ASTL) to Market Perform, Cuts PT to C$8
On Monday, BMO Capital downgraded Algoma Steel Group Inc. (NASDAQ:ASTL) to Market Perform from Outperform, while simultaneously lowering its price target to C$8 from C$12.
Regulators Approve Yogurt Deal Between General Mills, Inc. (GIS) and Lactalis in the U.S.
General Mills, Inc. (NYSE:GIS) and Lactalis announced that regulatory approval has been granted for the sale of General Mills’ US yogurt business to Lactalis.
Goldman Sachs Upgrades ArcBest (ARCB) to Buy, Raises PT to $101
On Monday, Goldman Sachs upgraded ArcBest Corporation (NASDAQ:ARCB) to Buy from Neutral and raised its price target to $101 from $84.
Novartis’ Pluvicto Shows Promise in Early Stage Prostate Cancer
On Monday, Novartis (NYSE:NVS) announced positive topline results from the Phase III PSMAddition trial, which showed that its targeted radioligand therapy/RLT, Pluvicto (lutetium...
BofA Lowers Runway Growth Finance (RWAY) PT to $9.75, Keeps Neutral Rating
On June 1, BofA updated its outlook on Runway Growth Finance Corp.
BofA Trims Kayne Anderson (KBDC) PT to $16.50, Cites Missed Estimates in Q1
On June 1, BofA adjusted its outlook on Kayne Anderson BDC Inc. (NYSE:KBDC) and lowered its price target from $17 to $16.50 while maintaining a Buy rating on the shares.
BofA Lowers Crescent Capital (CCAP) PT to $17 on Disappointing Q1 Results
On June 1, BofA adjusted its outlook on Crescent Capital BDC Inc. (NASDAQ:CCAP) and lowered its price target from $20 to $17 while maintaining a Buy rating.
Tempus AI Expands Tempus One with EHR Integration, New AI Features
On June 1, Tempus AI Inc.
Seer Launches Sample Study to Develop AI-Driven Cancer Diagnostics for Young Adults
On June 1, Seer Inc. (NASDAQ:SEER) announced a significant population-level study in collaboration with Korea University.
Daiichi Sankyo, AstraZeneca Announce Promising DATROWAY Combination Data in NSCLC
On June 1, Daiichi Sankyo Company Limited (OTC:DSNKY) and AstraZeneca (NASDAQ:AZN) announced promising results from 3 clinical trials: TROPION-Lung02, TROPION-Lung04, and NeoCOAST...
Allogene Therapeutics Presents Promising Phase 1 Data for ALLO-316 in Renal Cell Carcinoma
On June 1, Allogene Therapeutics Inc.
The Walt Disney Company (DIS) Laying Off Hundreds Across Multiple Teams, Media Reports
The Walt Disney Company (NYSE:DIS) is laying off several hundred employees globally, according to reports released on Monday.
Morgan Stanley Resumes Coverage of Alumis (ALMS) with $23 PT
On Monday, Morgan Stanley resumed its coverage of Alumis Inc.
Morgan Stanley Lifts Pebblebrook Hotel Trust (PEB) PT to $8, Keeps Underweight Rating
The rating update came when the firm raised estimates “modestly across the board” for its Gaming & Lodging coverage to take into account the better Q1 results, along with ...
Maxim Group Maintains Buy Rating on CERo Therapeutics (CERO)
In a report released on May 30, analyst Jason McCarthy from Maxim Group maintained a Buy rating on CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) with a $3.00 price target.
BofA Slashes Price Target on Cooper Companies (COO), Keeps Buy Rating
On May 30, BofA lowered the firm’s price target on Cooper Companies, Inc.
KeyBank Teams Up with Personetics to Enhance Financial Wellness Initiatives
KeyCorp (NYSE:KEY)'s subsidiary, KeyBank, is taking another step toward its goal of helping clients succeed by adopting Personetics’ Cognitive Banking platform, designed to ...
Morgan Stanley Reiterates Buy Rating on Costco (COST), Sets $1,225 PT
On May 30, Morgan Stanley analyst Simeon Gutman reiterated a Buy rating on Costco Wholesale Corporation (NASDAQ:COST) and set a price target of $1,225.00.
Jefferies Maintains Buy Rating on Costco (COST) After Q3 Report
On May 30, analyst Corey Tarlowe from Jefferies reiterated a Buy rating on Costco Wholesale Corporation (NASDAQ:COST), keeping the price target at $1,180.00.
JPMorgan Lifts CrowdStrike (CRWD) Price Target to $500, Maintains Overweight Rating
On June 2, JPMorgan analysts increased the price target for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) stock to $500 from $450 and maintained an Overweight.
Hedge Fund Resource Center
